Traws Pharma (TRAW) Misses Q2 EPS by 11c

Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.11). Revenue for the quarter came in at $2.73 million.

For earnings history and earnings-related data on Traws Pharma (TRAW) click here.

You May Also Be Interested In

• Tenable Holdings, Inc. (TENB) to Join S&P SmallCap 600
• Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance
• Berenberg Upgrades Vestas Wind Systems A/S (VWS:DC) (VWDRY) to Buy